Phosphate Diet Strategies to Lower Blood Phosphate in Dialysis Patients
Dietary Strategies for Hyperphosphatemia: A Randomized Controlled Study on the Effectiveness of Phosphate-Specific Interventions in Reducing Serum Phosphate Levels in Hemodialysis Patients in a Dialysis Center
1 other identifier
interventional
200
1 country
1
Brief Summary
Raised phosphate levels in the blood (hyperphosphatemia) are frequently observed in hemodialysis patients with chronic kidney failure. In addition to increasing the risk of life threatening complications like heart disease, severe bone disorders, and premature mortality, this condition also poses risks to overall health. Managing phosphate levels effectively is one of the central objectives in treating patients on dialysis. Control of dietary intake, particularly cutting out high phosphate foods, is one of the most effective ways of managing phosphate levels. Dietary restrictions can be challenging for most patients to adhere to, and effective educational tools for assisting them remain unclear. This clinical study aims to evaluate the impact of diet-derived education aimed solely at reducing phosphate levels in blood. Patients undergoing hemodialysis at a dialysis center will be randomly assigned to one of two groups. In addition to standard dietary advice, one group will receive targeted phosphate-specific dietary education which includes personalized counseling and aids to encourage selection of low-phosphate foods. The primary objective is to determine whether participants in the phosphate-specific education group achieve a greater reduction in blood phosphate levels over time as compared to those who receive standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 20, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedSeptember 18, 2025
September 1, 2025
3 months
July 20, 2025
September 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in serum phosphate concentration measured by standard blood test (mg/dL)
The primary outcome is the change in serum phosphate level from baseline to 12 weeks. Serum phosphate will be measured using venous blood samples and analyzed with an automated chemistry analyzer in the hospital laboratory.
Baseline and at weeks 4,8 and week 12
Study Arms (2)
Standard Dietary Advice"
NO INTERVENTIONRoutine general dietary advice for hemodialysis patients, not phosphate-focused.
Phosphate-Specific Dietary Education
OTHERIndividualized dietary education focused on reducing phosphate intake (food choices, portion control, additives).
Interventions
Individualized dietary education focused on reducing phosphate intake (food choices, portion control, additives).
Eligibility Criteria
You may qualify if:
- Males and females aged 18-60 years
- Stage 5 CKD patients on hemodialysis
- Receiving ≥2 weekly dialysis sessions for ≥2 months
- Written informed consent provided
- Ability (patient/caregiver) to read, write, and speak Arabic
You may not qualify if:
- Age \<18 or \>60
- Receiving \<2 dialysis sessions per week or \<2 months duration
- Refusal or inability to provide consent
- Severe mental illness or cognitive impairment
- Acute illness, infection, or hospitalization at enrollment
- Malabsorption conditions or prior GI surgery
- Noncompliance with medication or dialysis regimen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kufa Universitylead
Study Sites (1)
University of kufa
Najaf, 24001, Iraq
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 20, 2025
First Posted
September 18, 2025
Study Start
October 1, 2024
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
September 18, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL